Can MetLife's Group Benefits Segment Maintain Its Momentum?
MetLife's Group Benefits segment reported 25% year-over-year earnings growth in Q2 2026, driven by volume growth and improved underwriting. Group Life's mortality ratio improved to 79%, below the 83%-88% target range. However, some mortality benefits may not persist as about 2 percentage points reflected prior-period development. Competitors The Hartford and Aflac showed mixed results, with Hartford's employee benefits expanding but facing higher disability loss ratios, while Aflac's earnings declined despite sales growth.